First Report on the Treatment of Sleeping Sickness with Puromycin

Carlos Trincão Department of Hematology and Protozoology of the Institute of Tropical Medicine, Missão de Estudo e Combate à Doença do Sono na Guiné Portuguesa, Lisbon

Search for other papers by Carlos Trincão in
Current site
Google Scholar
PubMed
Close
,
Almeida Franco Department of Hematology and Protozoology of the Institute of Tropical Medicine, Missão de Estudo e Combate à Doença do Sono na Guiné Portuguesa, Lisbon

Search for other papers by Almeida Franco in
Current site
Google Scholar
PubMed
Close
,
Alfredo Nogueira Department of Hematology and Protozoology of the Institute of Tropical Medicine, Missão de Estudo e Combate à Doença do Sono na Guiné Portuguesa, Lisbon

Search for other papers by Alfredo Nogueira in
Current site
Google Scholar
PubMed
Close
,
A. R. Pinto Department of Hematology and Protozoology of the Institute of Tropical Medicine, Missão de Estudo e Combate à Doença do Sono na Guiné Portuguesa, Lisbon

Search for other papers by A. R. Pinto in
Current site
Google Scholar
PubMed
Close
, and
Heinz Mühlpfordt Department of Hematology and Protozoology of the Institute of Tropical Medicine, Missão de Estudo e Combate à Doença do Sono na Guiné Portuguesa, Lisbon

Search for other papers by Heinz Mühlpfordt in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

The results of the treatment of 15 cases of sleeping sickness by Puromycin are reported. Two months after the end of treatment, only two patients had relapsed; these were severe cases and had received relatively small doses of the antibiotic. Two other cases subsequently relapsed. Patients who did not relapse are under observation and will not receive any other specific therapy unless some new relapse is discovered. These patients are periodically controlled by lymph gland puncture, blood culture and cerebrospinal fluid examination. Toxic signs of the antibiotic were unimportant, taking the form mainly of diarrhea.

Author Notes

Save